Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Pneumococcal serotypes and antibiotic resistance in healthy carriage children after introduction of PCV13 in Lima, Peru

  • Brayan E. Gonzales
  • , Erik H. Mercado
  • , Franco Castillo-Tokumori
  • , Andrea E. Montero
  • , Alessandra Luna-Muschi
  • , Madhelli Marcelo-Ragas
  • , Francisco Campos
  • , Eduardo Chaparro
  • , Olguita Del Águila
  • , María E. Castillo
  • , Andrés Saenz
  • , Isabel Reyes
  • , Roger Hernandez
  • , Theresa J. Ochoa
  • Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical Alexander von Humboldt
  • Grupo Peruano de Investigación en Neumococo (GPIN)
  • Universidad Peruana Cayetano Heredia
  • San Bartolomé Mother-Child National Teaching Hospital
  • Hospital Nacional Cayetano Heredia
  • Hospital Nacionale Edgardo Rebagliati
  • Instituto Nacional de Salud Del Niño
  • Hospital Nacional Daniel Alcides Carrion
  • Hospital de Emergencias Pediátricas

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

8 Citas (Scopus)

Resumen

Objective: To determinate the frequency of Streptococcus pneumoniae nasopharyngeal carriers, serotypes and antimicrobial resistance in healthy children in Lima, Peru, post-PCV13 introduction and to compare the results with a similar study conducted between 2006 and 2008 before PCV7 introduction (pre-PCV7). Methods: A cross-sectional multicenter study was conducted between January 2018 and August 2019 in 1000 healthy children under two years of age. We use standard microbiological methods to determinate S. pneumoniae from nasopharyngeal swab, Kirby Bauer and minimum inhibitory concentration methods to determinate antimicrobial susceptibility and whole genomic sequencing to determinate pneumococcal serotypes. Results: The pneumococcal carriage rate was 20.8 % vs. 31.1 % in pre-PCV7 (p < 0.001). The most frequent serotypes were 15C, 19A and 6C (12.4 %, 10.9 % and 10.9 % respectively). The carriage of PCV13 serotypes after PCV13 introduction decreased from 59.1 % (before PCV7 introduction) to 18.7 % (p < 0.001). Penicillin resistance was 75.5 %, TMP/SMX 75.5 % and azithromycin 50.0 %, using disk diffusion. Penicillin resistance rates using MIC breakpoint for meningitis (MIC ≥ 0.12) increased from 60.4 % to 74.5 % (p = 0.001). Conclusion: The introduction of PCV13 in the immunization program in Peru has decreased the pneumococcal nasopharyngeal carriage and the frequency of PCV13 serotypes; however, there has been an increase in non-PCV13 serotypes and antimicrobial resistance.

Idioma originalInglés
Páginas (desde-hasta)4106-4113
Número de páginas8
PublicaciónVaccine
Volumen41
N.º28
DOI
EstadoPublicada - 23 jun. 2023

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

  1. ODS 3: Salud y bienestar
    ODS 3: Salud y bienestar

Citar esto